The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...
Like everything else in modern life, the landscape of food, health and nutrition is always evolving. Every year, there’s a ...
Ovation launches a GLP-1 dataset with WGS enabling biomaker discovery to advance precision medicine in metabolic diseases.
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback